XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Operating expenses        
Research and development expenses $ 3,150 $ 3,589 $ 5,021 $ 5,737
General and administrative expenses 1,464 802 2,963 1,535
Marketing expenses 182 100 310 170
Total operating expenses 4,796 4,491 8,294 7,442
Operating loss 4,796 4,491 8,294 7,442
Other (income) expense        
Change in fair value of derivative Liabilities (107) 3,269
Other (income) expense, net 96   92  
Finance income, net (29) (2) (66) (26)
Net Loss 4,756 4,489 11,589 7,416
Other comprehensive income:        
Foreign currency translation adjustment (29) (65) (6)
Comprehensive loss for the period $ 4,727 $ 4,489 $ 11,524 $ 7,410
Basic net loss per common stock $ 9.62 $ 984 $ 34.81 $ 1,700
Diluted net loss per common stock $ 9.62 $ 984 $ 34.81 $ 1,700
Weighted average number of common stock used in computing basic loss per common stock 494,504 4,564 332,931 4,363
Weighted average number of common stock used in computing diluted loss per common stock 494,504 4,564 332,931 4,363